.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Baxter
Johnson and Johnson
Daiichi Sankyo
Argus Health
Julphar
Queensland Health
Citi
Fish and Richardson
Express Scripts

Generated: July 22, 2017

DrugPatentWatch Database Preview

Hisamitsu Pharm Co Company Profile

« Back to Dashboard

What is the competitive landscape for HISAMITSU PHARM CO, and when can generic versions of HISAMITSU PHARM CO drugs launch?

HISAMITSU PHARM CO has one approved drug.

There are two US patents protecting HISAMITSU PHARM CO drugs.

There are seventeen patent family members on HISAMITSU PHARM CO drugs in fourteen countries.

Summary for Applicant: Hisamitsu Pharm Co

Patents:2
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-002Nov 5, 2012OTCYesNo9,233,184► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-001Feb 20, 2008OTCYesYes9,233,184► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-002Nov 5, 2012OTCYesNo8,809,615► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-001Feb 20, 2008OTCYesYes8,809,615► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Hisamitsu Pharm Co

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,455,376Adhesive preparation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Hisamitsu Pharm Co Drugs

Country Document Number Estimated Expiration
European Patent Office2047845► Subscribe
Mexico2008014574► Subscribe
TaiwanI414299► Subscribe
BrazilPI0712396► Subscribe
Singapore174034► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Farmers Insurance
Queensland Health
Chinese Patent Office
UBS
Citi
Cerilliant
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot